susvimo

Generic: ranibizumab

Labeler: genentech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name susvimo
Generic Name ranibizumab
Labeler genentech, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVITREAL
Active Ingredients

ranibizumab 100 mg/mL

Manufacturer
Genentech, Inc.

Identifiers & Regulatory

Product NDC 50242-078
Product ID 50242-078_2850382e-4e4f-4005-a047-33fc758bafef
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761197
Listing Expiration 2026-12-31
Marketing Start 2021-10-22

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50242078
Hyphenated Format 50242-078

Supplemental Identifiers

RxCUI
2584857 2584863
UNII
ZL1R02VT79
NUI
N0000193542 N0000193543

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name susvimo (source: ndc)
Generic Name ranibizumab (source: ndc)
Application Number BLA761197 (source: ndc)
Routes
INTRAVITREAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (50242-078-12) / 1 mL in 1 VIAL
  • 1 VIAL in 1 CARTON (50242-078-55) / 1 mL in 1 VIAL
source: ndc

Packages (2)

50242-078-12 1 VIAL in 1 CARTON (50242-078-12) / 1 mL in 1 VIAL 50242-078-55 1 VIAL in 1 CARTON (50242-078-55) / 1 mL in 1 VIAL

Ingredients (1)

ranibizumab (100 mg/mL)

Linked Drug Pages (1)

Susvimo ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVITREAL"], "spl_id": "2850382e-4e4f-4005-a047-33fc758bafef", "openfda": {"nui": ["N0000193542", "N0000193543"], "unii": ["ZL1R02VT79"], "rxcui": ["2584857", "2584863"], "spl_set_id": ["9c6d9e2a-9a77-4d11-b692-de87cfde3444"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (50242-078-12)  / 1 mL in 1 VIAL", "package_ndc": "50242-078-12", "marketing_start_date": "20211022"}, {"sample": false, "description": "1 VIAL in 1 CARTON (50242-078-55)  / 1 mL in 1 VIAL", "package_ndc": "50242-078-55", "marketing_end_date": "20270930", "marketing_start_date": "20211022"}], "brand_name": "Susvimo", "product_id": "50242-078_2850382e-4e4f-4005-a047-33fc758bafef", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "product_ndc": "50242-078", "generic_name": "Ranibizumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Susvimo", "active_ingredients": [{"name": "RANIBIZUMAB", "strength": "100 mg/mL"}], "application_number": "BLA761197", "marketing_category": "BLA", "marketing_start_date": "20211022", "listing_expiration_date": "20261231"}